Paul Mampilly has enjoyed a fine career on Wall Street as a hedge fund manager who demonstrated a rare level of ability with his various postings at financial firms. He’s worked at several places that are household names in the world of finance such as ING and Deutsche Bank to name a couple. He’s been featured on financial television on outlets like Fox Business News after his victory in the Templeton Foundation’s investing contest. With all of this success in hand, he’s figured out a way to cut back from the frantic pace of Wall Street and help others on their own road to financial achievement. Read more at PRNewswire about Paul Mampilly.
The retirement of Paul Mampilly at age 42 must have raised a few eyebrows but he still competes in the financial world on a different playing field. His extraordinary acumen for analyzing market trends and stock picking is now conducted on behalf of ordinary investors. It’s his way of paying it forward and sharing his successful methods with anyone who desires a nice retirement or just greater financial stability.
Unlimited Profits is his newsletter where he highlights the stocks with the greatest potential to rise quickly. It has shown steady growth since its inception and the subscribers are approaching 100,000 in number. Two trends stick out in the mind of Paul Mampilly and he believes that they will be the main drivers of markets going forward.
The Internet of Things and the Millenials will have an enormous impact on the economy and opportunities for investors will abound in these categories. Profits Unlimited has a strong emphasis on these two factors and for a nominal price, investors can get into trends early with minimal risk. This is how Paul Mampilly invests and what he teaches with his publications.
The ability to accurately assess innovative companies has characterized the career of Paul Mampilly and one example of this is his investment in Sarepta Therapeutics. He got on board early and had an extraordinary success as an investor in this stock. His analysis that their new drug for muscular dystrophy would be a success proved to be correct and he rode the stock higher with a more than 2000% gain. It is just these types of situations that he seeks to uncover and has demonstrated an uncanny ability to do so. Taking a calculated risk has been one of Mampilly’s chief attributes that have brought him success and he teaches his readers how to do the same. Read this article at Daily Forex Report.